台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    84.3
  • 漲跌
    ▼1.4
  • 漲幅
    -1.63%
  • 成交量
    200
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
旭富 (4119)籌碼相關-玉山-板橋 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-板橋 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22184.8000.0085.7012720.37%
2025/01/20183.9000.0084.8012720.37%
2024/12/130.292.5000.0090.600.22380.07%
2024/12/031097.001697.4197.80-6216-2.77%
2024/12/022097.5000.0096.10202049.79%
2024/11/2900.00195.5096.20-1199-0.50%
2024/11/20198.001997.8997.80-18172-10.42%
2024/11/1300.00295.5096.00-2136-1.47%
2024/11/1200.00194.3094.30-1123-0.81%
2024/11/1100.001193.5093.30-11112-9.80%
2024/11/061189.4400.0089.40119611.44%
2024/10/110.190.4000.0091.000.11330.04%
2024/09/11086.9000.0087.3001570.01%
2024/09/1000.00187.5086.70-1158-0.63%
2024/09/0500.00387.4086.50-3160-1.87%
2024/09/04286.35187.2087.0011650.60%
2024/08/27188.8000.0088.8011740.57%
2024/08/21189.1000.0089.4011800.55%
2024/08/06286.55188.0088.9012180.46%
2024/08/051.185.9300.0086.601.12140.49%
2024/07/3000.000.290.6091.00-0.2204-0.10%
2024/07/260.291.0000.0091.500.22010.10%
2024/07/2200.00290.7090.80-2202-0.99%
2024/07/19291.5000.0091.6022010.99%
2024/07/18192.4000.0092.7011990.50%
2024/07/1600.00292.5092.70-2197-1.01%
2024/07/15191.20292.8592.80-1202-0.49%
2024/07/101.191.4000.0091.601.12040.51%
2024/07/09391.4000.0091.8032051.46%
2024/07/03291.3500.0091.4022060.97%
2024/07/02991.0400.0091.2092064.36%
2024/07/01489.5800.0089.9042031.96%
2024/06/28190.1000.0090.4012050.49%
2024/06/27190.2000.0090.1012040.49%
2024/06/26190.5000.0090.5012030.49%
2024/06/1900.00190.4090.20-1205-0.49%
2024/06/1800.00290.3090.40-2206-0.97%
2024/06/1400.00690.0390.10-6210-2.85%
2024/06/1300.00190.1090.00-1212-0.47%
2024/06/11391.1300.0090.2032141.40%
2024/06/07192.8000.0093.1012160.46%
2024/06/05192.8000.0092.9012200.45%
2024/05/3000.00292.3092.50-2230-0.87%
2024/05/2800.00192.6092.50-1235-0.42%
2024/05/23391.43191.4091.3022350.85%
2024/05/2200.000.392.5092.40-0.3235-0.11%
2024/05/21192.1000.0092.1012350.42%
2024/05/20594.2600.0093.4052332.14%
2024/05/17793.50593.3093.9022300.87%
2024/05/16192.2000.0092.5012250.44%
2024/05/09188.60188.6088.5002430.00%
2024/05/0700.00188.6088.10-1242-0.41%
2024/04/2900.00189.0089.20-1246-0.41%
2024/04/25187.6000.0088.5012450.41%
2024/04/1800.00488.5088.30-4250-1.60%
2024/04/16387.4700.0087.4032491.20%
2024/04/15287.9500.0087.7022520.79%
2024/04/1000.00489.5589.50-4261-1.53%
2024/04/09388.73289.0088.9012610.38%
2024/04/020.189.2000.0088.600.12590.02%
2024/03/282.188.4500.0088.302.12580.79%
2024/03/22187.2000.0087.6012650.38%
2024/03/20087.7800.0087.6002780.00%
2024/03/18087.5000.0086.9002840.00%
2024/03/150.287.60087.6587.400.22850.07%
2024/03/14187.8000.0087.2012860.35%
2024/03/1200.00289.1089.00-2278-0.72%
2024/03/11189.2000.0089.1012750.36%
2024/03/081.190.4100.0090.401.12730.38%
2024/03/01591.6200.0091.4052741.82%
2024/02/291.191.3900.0091.201.12810.37%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章